1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Farm Animal Drugs Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Farm Animal Drugs Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising demand for animal-derived food products
- 5.1.2 Need to prevent diseases in farm animals
5.2 Market Opportunities
- 5.2.1 Expanding demand for veterinary health products in developing regions
- 5.2.2 Growth in animal health technologies
5.3 Future Trends
- 5.3.1 Increasing use of antibiotics and vaccines
- 5.3.2 Rise in farm animal vaccination programs
5.4 Impact of Drivers and Restraints
6. Europe Farm Animal Drugs Market Regional Analysis
6.1 Europe Farm Animal Drugs Market Overview
6.2 Europe Farm Animal Drugs Market Revenue 2019-2028 (US$ Million)
6.3 Europe Farm Animal Drugs Market Forecast Analysis
7. Europe Farm Animal Drugs Market Analysis – by Product Type
7.1 Anti-Infective
- 7.1.1 Overview
- 7.1.2 Anti-Infective: Europe Farm Animal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Parasiticides
- 7.2.1 Overview
- 7.2.2 Parasiticides: Europe Farm Animal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Anti-inflammatory
- 7.3.1 Overview
- 7.3.2 Anti-inflammatory: Europe Farm Animal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Anesthetics
- 7.4.1 Overview
- 7.4.2 Anesthetics: Europe Farm Animal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Analgesics
- 7.5.1 Overview
- 7.5.2 Analgesics: Europe Farm Animal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Hormones
- 7.6.1 Overview
- 7.6.2 Hormones: Europe Farm Animal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Related Product
- 7.7.1 Overview
- 7.7.2 Related Product: Europe Farm Animal Drugs Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Farm Animal Drugs Market Analysis – by Animal Type
8.1 Livestock Animal
- 8.1.1 Overview
- 8.1.2 Livestock Animal: Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Equine
- 8.2.1 Overview
- 8.2.2 Equine: Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Farm Animal Drugs Market Analysis – by Route of Administration
9.1 Oral
- 9.1.1 Overview
- 9.1.2 Equine: Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Parenteral
- 9.2.1 Overview
- 9.2.2 Equine: Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Topical
- 9.3.1 Overview
- 9.3.2 Equine: Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Farm Animal Drugs Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Farm Animal Drugs Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 Europe Farm Animal Drugs Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Farm Animal Drugs Market Breakdown, by Product Type
- 10.1.1.1.2 UK: Europe Farm Animal Drugs Market Breakdown, by Animal Type
- 10.1.1.1.3 UK: Europe Farm Animal Drugs Market Breakdown, by Route of Administration
- 10.1.1.2 Germany:
Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Farm Animal Drugs Market Breakdown, by Product Type
- 10.1.1.2.2 Germany: Europe Farm Animal Drugs Market Breakdown, by Animal Type
- 10.1.1.2.3 Germany: Europe Farm Animal Drugs Market Breakdown, by Route of Administration
- 10.1.1.3 France:
Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Farm Animal Drugs Market Breakdown, by Product Type
- 10.1.1.3.2 France: Europe Farm Animal Drugs Market Breakdown, by Animal Type
- 10.1.1.3.3 France: Europe Farm Animal Drugs Market Breakdown, by Route of Administration
- 10.1.1.4 Russia:
Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Farm Animal Drugs Market Breakdown, by Product Type
- 10.1.1.4.2 Russia: Europe Farm Animal Drugs Market Breakdown, by Animal Type
- 10.1.1.4.3 Russia: Europe Farm Animal Drugs Market Breakdown, by Route of Administration
- 10.1.1.5 Italy:
Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Farm Animal Drugs Market Breakdown, by Product Type
- 10.1.1.5.2 Italy: Europe Farm Animal Drugs Market Breakdown, by Animal Type
- 10.1.1.5.3 Italy: Europe Farm Animal Drugs Market Breakdown, by Route of Administration
- 10.1.1.6 Rest of Europe:
Europe Farm Animal Drugs Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Farm Animal Drugs Market Breakdown, by Product Type
- 10.1.1.6.2 Rest of Europe: Europe Farm Animal Drugs Market Breakdown, by Animal Type
- 10.1.1.6.3 Rest of Europe: Europe Farm Animal Drugs Market Breakdown, by Route of Administration
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Farm Animal Drugs Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 PHIBRO ANIMAL HEALTH CORPORATION
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Zoetis Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Ceva
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Elanco
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Virbac
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 INTAS PHARMACEUTICALS LTD.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Alembic Pharmaceuticals Limited
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Boehringer Ingelheim International GmbH
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 MSD Animal Health
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Vetoquinol SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights